The inventor of the Eyerising International repeated low-level red light (RLRL) therapy for myopia, Professor Mingguang He, has outlined “notable...
Read moreDetailsAt the completion of this article, the reader should be able to improve their knowledge of emerging myopia control interventions,...
Read moreDetailsEssilorLuxottica has unveiled new six-year clinical data at the 2025 China Optometry & Ophthalmology Conference (COOC), reinforcing the long-term efficacy...
Read moreDetailsSydney optometrist DR OLIVER WOO explains why colleagues need to be on the look out for pre-myopes and how prescribing...
Read moreDetailsHe’s only just had the upgrade installed but already this optometry practice owner is seeing the need for others to...
Read moreDetailsAt the completion of this article, the reader should be able to discuss RLRL with their myopia patients, including: Understand...
Read moreDetailsRepeated low-level red-light (RLRL) device manufacturer Eyerising International says the reclassification of the emerging myopia management intervention in China is...
Read moreDetailsAt the completion of this article, the reader should be able to improve their myopia management approach, including... Recognise the...
Read moreDetailsAustralian eyecare professionals are confident in the nation’s ability to combat the global myopia epidemic. Equipped with industry-leading products, a...
Read moreDetailsTokyo Medical and Dental University (TMDU) will introduce the Eyerising Myopia Management Device for its myopia patients as part of...
Read moreDetailsInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited